Universities Participate In Pharmaceutical Society Of Japan Workshop
This article was originally published in PharmAsia News
A workshop sponsored by the Pharmaceutical Society of Japan was held Aug. 7-8 in Tokyo for students across the country.
You may also be interested in...
NeuClone has reported that its NeuCeptin proposed biosimilar trastuzumab has successfully met all primary and secondary endpoints in a Phase I clinical trial.
Products from Novartis, Celgene and Merck could get an EU approval recommendation at this week's CHMP meeting.